• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Astrotech Corporation

    4/19/21 10:19:14 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email
    SC 13G 1 tm2113314d1_sc13g.htm SC 13G

     

     

     

    CUSIP No: 046484200

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

     

    (Rule 13d-102)

     

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2.

     

    (Amendment No. ____)*

     

    Astrotech Corporation
    (Name of Issuer)

     

    Common Stock, $0.001 par value per share

    (Title of Class of Securities)

     

    046484200
    (CUSIP Number)

     

    April 8, 2021

    (Date of Event Which Requires Filing of this statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)
    xRule 13d-1(c)
    ¨Rule 13d-1(d)

     

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No: 046484200

     

    (1)NAMES OF REPORTING PERSONS
       
      CVI Investments, Inc.
       
     (2)CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      (SEE INSTRUCTIONS)
       
      (a)    ¨
      (b)    ¨
       
     (3)SEC USE ONLY
       
     (4)CITIZENSHIP OR PLACE OF ORGANIZATION
       
      Cayman Islands
       

    NUMBER OF(5)SOLE VOTING POWER
       
    SHARES0 
       
    BENEFICIALLY(6)SHARED VOTING POWER **
       
       3,500,000
    OWNED BY  
       
    EACH(7)SOLE DISPOSITIVE POWER
       
    REPORTING0 
       
    PERSON WITH(8)SHARED DISPOSITIVE POWER **
       
       3,500,000
      

      (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
        3,500,000
         
      (10) CHECK BOX IF THE AGGREGATE AMOUNT
        IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
         
        ¨ 
         
      (11) PERCENT OF CLASS REPRESENTED
        BY AMOUNT IN ROW (9)
         
        7.6%
         
      (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
        CO
         

    ** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

     

     

     

    CUSIP No: 046484200

     

    (1)NAMES OF REPORTING PERSONS
       
      Heights Capital Management, Inc.
       
     (2)CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      (SEE INSTRUCTIONS)
       
      (a)    ¨
      (b)    ¨
       
     (3)SEC USE ONLY
       
     (4)CITIZENSHIP OR PLACE OF ORGANIZATION
       
      Delaware
       

    NUMBER OF(5)SOLE VOTING POWER
       
    SHARES0 
       
    BENEFICIALLY(6)SHARED VOTING POWER **
       
       3,500,000
    OWNED BY  
       
    EACH(7)SOLE DISPOSITIVE POWER
       
    REPORTING0 
       
    PERSON WITH(8)SHARED DISPOSITIVE POWER **
       
       3,500,000
      

      (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
        3,500,000
         
      (10) CHECK BOX IF THE AGGREGATE AMOUNT
        IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
         
        ¨ 
         
      (11) PERCENT OF CLASS REPRESENTED
        BY AMOUNT IN ROW (9)
         
        7.6%
         
      (12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
        CO
         

    ** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

     

     

     

    CUSIP No: 046484200

     

    Item 1.

     

    (a)    Name of Issuer

     

    Astrotech Corporation (the “Company”)

     

    (b)    Address of Issuer’s Principal Executive Offices

     

    2028 E Ben White Blvd., Suite 240-9530, Austin, TX, 78741

     

    Item 2(a).         Name of Person Filing

     

    This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons,” with respect to the shares of common stock of the Company, $0.001 par value per share (the “Shares”).

     

    (i)CVI Investments, Inc.

     

    (ii)Heights Capital Management, Inc.

     

    Item 2(b).       Address of Principal Business Office or, if none, Residence

     

    The address of the principal business office of CVI Investments, Inc. is:

     

    P.O. Box 309GT

    Ugland House

    South Church Street

    George Town

    Grand Cayman

    KY1-1104

    Cayman Islands

     

    The address of the principal business office of Heights Capital Management, Inc. is:

     

    101 California Street, Suite 3250

    San Francisco, California 94111

     

    Item 2(c).        Citizenship

     

    Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    Item 2(d)         Title of Class of Securities

     

    Common stock, $0.001 par value per share

     

    Item 2(e)         CUSIP Number

     

    046484200

     

    Item 3.            If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

     

     

     

    CUSIP No: 046484200

     

    (b)¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

     

    (c)¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

     

    (d)¨ Investment company registered under Section 8 of the Investment
    Company Act of 1940 (15 U.S.C. 80a-8).

     

    (e)¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     

    (f)¨ An employee benefit plan or endowment fund in accordance with
    §240.13d-1(b)(1)(ii)(F);

     

    (g)¨ A parent holding company or control person in accordance with
    §240.13d-1(b)(1)(ii)(G);

     

    (h)¨ A savings association as defined in Section 3(b) of the Federal
    Deposit Insurance Act (12 U.S.C. 1813);

     

    (i)¨ A church plan that is excluded from the definition of an investment

    company under Section 3(c)(14) of the Investment Company Act of 1940

    (15 U.S.C. 80a-3);

     

    (j)¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

     

    (k)¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ________________

     

    Item 4.            Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    The Company’s Prospectus Supplement (to Prospectus dated March 15, 2021, Registration No. 333-253835), filed on April 9, 2021, indicates there were 46,253,181 Shares outstanding as of the completion of the offering of the Shares referred to therein.

     

    Heights Capital Management, Inc., which serves as the investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.

     

    Item 5.            Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨

     

    Item 6.            Ownership of More than Five Percent on Behalf of Another Person

     

    Not applicable.

     

     

     

    CUSIP No: 046484200

     

    Item 7.             Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

     

    Not applicable.

     

    Item 8.             Identification and Classification of Members of the Group

     

    Not applicable.

     

    Item 9.             Notice of Dissolution of Group

     

    Not applicable.

     

    Item 10.          Certification

     

    By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

    CUSIP No: 046484200

     

    SIGNATURES

     

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

     

    Dated: April 19, 2021

     

    CVI INVESTMENTS, INC. HEIGHTS CAPITAL MANAGEMENT, INC.
       
    By: Heights Capital Management, Inc. By: /s/ Brian Sopinsky
    pursuant to a Limited Power of Name: Brian Sopinsky
    Attorney, a copy of which is attached Title:     Secretary
    as Exhibit I hereto  

     

    By: /s/ Brian Sopinsky  
    Name: Brian Sopinsky  
    Title:     Secretary  

     

     

     

    CUSIP No: 046484200

     

    EXHIBIT INDEX

     

    EXHIBIT   DESCRIPTION
    I   Limited Power of Attorney
    II   Joint Filing Agreement

     

     

     

    CUSIP No: 046484200

     

    Exhibit I

     

    LIMITED POWER OF ATTORNEY

     

    THIS LIMITED POWER OF ATTORNEY given on the 16th day of July, 2015 by CVI Investments, Inc. (hereinafter called "the Company"), whose Registered Office is situated at PO Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands.

     

    WHEREAS, by agreement dated July 16, 2015, by and between the Company and Heights Capital Management, Inc., the Company expressly authorized Heights Capital Management, Inc. to enter into transactions in certain designated areas as defined in the Discretionary Investment Management Agreement attached hereto marked "Appendix l."

     

    NOW THIS DEED WITNESSETH that William Walmsley, Director of the Company, hereby appoints on behalf of the Company the firm of HEIGHTS CAPITAL MANAGEMENT, INC., which through its officers, directors and employees is hereby formally granted limited power of attorney for the purpose of entering into transactions on behalf and for the account of the Company; and to take all actions on behalf of the Company as may be necessary to consummate such transactions, including but not limited to making, negotiating; signing, endorsing, executing, acknowledging and delivering in the name of the Company all applications, contracts, agreements, notes, statements, certificates, proxies and any other instruments of whatever kind and nature as may be necessary or proper in connection with the entering into of such transactions, instructing the transfer of funds where necessary with respect to such transactions, and performing all of the services specified under the Discretionary Investment Management Agreement with respect to such transactions.

     

    IN WITNESS WHEREOF, the Company has caused this Limited Power of Attorney to take effect on the day and year above written.

     

      CVI Investments, Inc.
       
       
      By:    /s/ William Walmsley
        William Walmsley, Director

     

     

     

    CUSIP No: 046484200

     

    EXHIBIT II

     

    JOINT FILING AGREEMENT

     

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of common stock of Astrotech Corporation, $0.001 par value per share, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

     

    Dated as of April 19, 2021

     

    CVI INVESTMENTS, INC. HEIGHTS CAPITAL MANAGEMENT, INC.
       
    By: Heights Capital Management, Inc. By: /s/ Brian Sopinsky
    pursuant to a Limited Power of Attorney Name: Brian Sopinsky
      Title:     Secretary

     

    By: /s/ Brian Sopinsky  
    Name: Brian Sopinsky  
    Title:     Secretary  

     

    Get the next $ASTC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Astrotech Reports Third Quarter of Fiscal Year 2025 Financial Results

      AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the third quarter of fiscal year 2025, which ended March 31, 2025. Thomas B. Pickens, III, Astrotech's Chairman, Chief Executive Officer and Chief Technology Officer, said, "Our customizable, portable and field updatable mass spectrometry instruments have the potential to be a game changer in a growing list of large end markets such as airport security and cargo scanning, narcotics detection, environmental monitoring and chemical processing. I am very proud of our team's accomplishments, as we now have launched four product lines that we bel

      5/13/25 4:30:00 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances

      AUSTIN, Texas, March 10, 2025 (GLOBE NEWSWIRE) --  Astrotech Corporation (NASDAQ:ASTC) today announced the launch of its enhanced TRACER 1000™ Narcotics Trace Detector ("TRACER 1000 NTD") from its 1st Detect subsidiary. This innovative mobilized mass spectrometer is specifically configured to screen for the full range of synthetic opiates and novel psychoactive substances ("NPS"), delivering accuracy and speed to counter the global drug crisis. Improving Drug Detection with Advanced Mass Spectrometry The latest iteration of the TRACER 1000 NTD represents a significant leap forward in portable trace detection. Unlike conventional methods, the TRACER 1000 NTD leverages cutting-edge mass sp

      3/10/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Creates New Subsidiary EN-SCAN, Inc.

      AUSTIN, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has created a new wholly owned subsidiary, EN-SCAN, Inc. ("EN-SCAN"), to manufacture and sell a new line of instruments built for environmental testing applications using its proprietary ATi Gas Chromatograph ("GC") and Astrotech Mass Spectrometer Technology™ ("MS"). The EN-SCAN product line has been designed for outdoor field work that can be used on-site for real-time air, water, and soil analysis providing instant feedback for accurate contamination source location and migration. "EN-SCAN has been developed to fill a gap in the environmental testing market needing a durable and

      2/28/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    See more
    • Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business

      AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer. "I will be moving to Houston to be closer to family and to work for our family business," said Mr. Hinojosa. "I am grateful to Tom Pickens,

      1/24/25 8:30:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

      AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the first quarter of fiscal year 2024, which ended September 30, 2023. Financial Highlights & Recent Developments  Astrotech's consolidated balance sheet remains strong with $39 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.Revenue for the quarter totaled $425 thousand compared to $38 thousand in the first quarter of the prior year due primarily to ongoing fulfillment of the previously announced 17-unit order for the TRACER 1000™ expl

      11/13/23 4:30:30 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company's Innovative Product Pipeline Continues to Grow (Updated with Additional Details)

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of corporate governance, finance, operations, technology, M&A, advisory and CEO experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a

      10/31/23 11:54:15 AM ET
      $ASTC
      $LGMK
      $SONM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Industrial Specialties
      Health Care

    $ASTC
    SEC Filings

    See more
    • SEC Form 10-Q filed by Astrotech Corporation (DE)

      10-Q - ASTROTECH Corp (0001001907) (Filer)

      5/14/25 9:20:19 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ASTROTECH Corp (0001001907) (Filer)

      5/13/25 4:33:56 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Corporation (DE) filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ASTROTECH Corp (0001001907) (Filer)

      3/10/25 8:31:49 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/30/24 9:16:58 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/28/24 9:46:54 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/21/24 12:54:36 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mcfarland Robert N was granted 3,000 shares, increasing direct ownership by 28% to 13,900 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 11:38:34 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Director Stober Eric was granted 3,000 shares, increasing direct ownership by 41% to 10,331 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 10:47:45 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • CEO Pickens Thomas Boone Iii was granted 50,000 shares, increasing direct ownership by 38% to 181,385 units (SEC Form 4)

      4 - ASTROTECH Corp (0001001907) (Issuer)

      5/16/25 10:46:04 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $ASTC
    Financials

    Live finance-specific insights

    See more
    • SEC Form SC 13D filed by Astrotech Corporation (DE)

      SC 13D - ASTROTECH Corp (0001001907) (Subject)

      6/26/23 4:00:53 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

      SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

      2/8/23 5:29:16 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

      SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

      2/8/23 4:02:50 PM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

      Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

      4/8/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

      AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

      4/2/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

       AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

      3/25/24 9:00:00 AM ET
      $ASTC
      Biotechnology: Laboratory Analytical Instruments
      Industrials